$241 Million is the total value of Artia Global Partners LP's 27 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 20.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVO | Buy | NOVO-NORDISK A Sadr | $62,003,983 | +12.4% | 681,812 | +100.0% | 25.78% | +35.5% |
| MRK | MERCK & CO INC | $33,891,140 | -10.8% | 329,200 | 0.0% | 14.09% | +7.6% | |
| ARGX | Buy | ARGENX SEsponsored adr | $24,206,878 | +33.8% | 49,238 | +6.0% | 10.06% | +61.3% |
| LLY | Buy | LILLY ELI & CO | $14,069,046 | +85.3% | 26,193 | +61.8% | 5.85% | +123.4% |
| ABBV | ABBVIE INC | $13,537,778 | +10.6% | 90,821 | 0.0% | 5.63% | +33.4% | |
| AZN | ASTRAZENECA PLCsponsored adr | $12,917,725 | -5.4% | 190,752 | 0.0% | 5.37% | +14.1% | |
| SGEN | SEAGEN INC | $10,856,776 | +10.2% | 51,175 | 0.0% | 4.51% | +32.9% | |
| Buy | ROIVANT SCIENCES LTD | $10,675,789 | +28.5% | 914,023 | +10.9% | 4.44% | +55.0% | |
| ETNB | 89BIO INC | $7,186,780 | -18.5% | 465,465 | 0.0% | 2.99% | -1.7% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,942,583 | +2.1% | 78,465 | 0.0% | 2.89% | +23.1% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $6,929,178 | -21.6% | 57,162 | -25.9% | 2.88% | -5.4% |
| VRTX | VERTEX PHARMACEUTICALS INC | $6,368,510 | -1.2% | 18,314 | 0.0% | 2.65% | +19.1% | |
| AXSM | AXSOME THERAPEUTICS INC | $6,139,697 | -2.7% | 87,848 | 0.0% | 2.55% | +17.3% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $5,062,500 | +19.3% | 45,000 | 0.0% | 2.10% | +43.8% | |
| VKTX | VIKING THERAPEUTICS INC | $4,246,231 | -31.7% | 383,580 | 0.0% | 1.76% | -17.6% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $2,828,464 | -6.8% | 15,971 | 0.0% | 1.18% | +12.4% | |
| ITCI | INTRA-CELLULAR THERAPIES INC | $2,166,944 | -17.7% | 41,600 | 0.0% | 0.90% | -0.8% | |
| PCVX | VAXCYTE INC | $1,965,534 | +2.1% | 38,555 | 0.0% | 0.82% | +23.0% | |
| PTGX | PROTAGONIST THERAPEUTICS INC | $1,873,831 | -39.6% | 112,340 | 0.0% | 0.78% | -27.2% | |
| PLRX | PLIANT THERAPEUTICS INC | $1,734,000 | -4.3% | 100,000 | 0.0% | 0.72% | +15.4% | |
| CRL | CHARLES RIV LABS INTL INC | $1,353,242 | -6.8% | 6,905 | 0.0% | 0.56% | +12.6% | |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $1,067,513 | -59.8% | 2,109 | -58.5% | 0.44% | -51.5% |
| WAT | WATERS CORP | $780,127 | +2.9% | 2,845 | 0.0% | 0.32% | +24.1% | |
| TYRA BIOSCIENCES INC | $623,134 | -19.1% | 45,253 | 0.0% | 0.26% | -2.6% | ||
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $615,202 | -66.8% | 41,261 | -75.6% | 0.26% | -59.9% |
| BMEA | BIOMEA FUSION INC | $350,220 | -37.3% | 25,452 | 0.0% | 0.15% | -24.4% | |
| GRTS | GRITSTONE BIO INC | $163,692 | -11.8% | 95,170 | 0.0% | 0.07% | +6.2% | |
| MOR | Exit | MORPHOSYS AGsponsored ads | $0 | – | -43,499 | -100.0% | -0.11% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -37,108 | -100.0% | -1.38% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -102,940 | -100.0% | -3.23% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -244,861 | -100.0% | -3.32% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -543,358 | -100.0% | -3.53% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -84,719 | -100.0% | -3.55% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -52,275 | -100.0% | -5.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVO-NORDISK A S | 4 | Q3 2023 | 25.8% |
| MERCK & CO INC | 4 | Q3 2023 | 14.1% |
| ARGENX SE | 4 | Q3 2023 | 12.3% |
| LILLY ELI & CO | 4 | Q3 2023 | 14.5% |
| ABBVIE INC | 4 | Q3 2023 | 5.6% |
| ASTRAZENECA PLC | 4 | Q3 2023 | 5.4% |
| SEAGEN INC | 4 | Q3 2023 | 4.5% |
| BIOMARIN PHARMACEUTICAL INC | 4 | Q3 2023 | 4.3% |
| NEUROCRINE BIOSCIENCES INC | 4 | Q3 2023 | 2.1% |
| VERTEX PHARMACEUTICALS INC | 4 | Q3 2023 | 2.6% |
View Artia Global Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Artia Global Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.